← Browse by Condition
Medical Condition

refractory focal epilepsy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07219407 Phase 2
Recruiting

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Enrollment
30 pts
Location
United States
Sponsor
Rapport Therapeutics Inc.
View Trial →